Fierce Pharma

APRIL 28, 2023

EU plots major pharma reforms—but industry is already pushing back zbecker Fri, 04/28/2023 - 18:04

Pharma 267

Pharma 267

MedCity News

MARCH 24, 2024

based pharma companies. The survey was conducted in late 2023 and results were reported this month. Lack of automation is the top challenge facing commercialization teams, according to a survey of executives at U.S.-based

Pharma 263

Pharma Biopharma 263

Fierce Pharma

APRIL 20, 2023

The Top Line': How Pfizer became the first in Big Pharma history to break $100B in sales, plus this week's headlines tcarey Thu, 04/20/2023 - 14:46

Sales 288

Sales Pharma 288

Fierce Pharma

JANUARY 31, 2023

Pfizer warns Comirnaty sales will plummet by nearly two-thirds in 2023. And Paxlovid won't fare much better kdunleavy Tue, 01/31/2023 - 10:58

Sales 334

Sales 334

Fierce Pharma

JANUARY 19, 2023

Fierce Pharma Asia—China's reimbursement round; Sun's alopecia bet; GenScript's CDMO raise aliu Thu, 01/19/2023 - 15:53

Pharma 253

Pharma 253

Fierce Pharma

MAY 8, 2023

Pfizer, AstraZeneca run it back in IDEA Pharma's annual innovation rankings kdunleavy Mon, 05/08/2023 - 10:21

Pharma 246

Pharma 246

Fierce Pharma

MAY 12, 2023

As pharma fights IRA, Senate moves forward basket of bills aimed at lower drug prices aliu Fri, 05/12/2023 - 10:48

Pharma 257

Pharma 257

Fierce Pharma

DECEMBER 20, 2022

2023 forecast: With Novo's Wegovy on a supply rebound, 2023 offers course correction and obesity showdown with Lilly. fkansteiner. Tue, 12/20/2022 - 10:26.

262

262

Fierce Pharma

JANUARY 9, 2023

in COVID vaccine sales last year, projects at least $5B in 2023. Mon, 01/09/2023 - 10:34. JPM23: Moderna reaped $18.4B

Sales 307

Sales 307

MedCity News

DECEMBER 29, 2022

Many pharma and medical device companies will look inward, with the goal of standardizing and modernizing even highly regulated activities. Here’s a closer look at some important industry trends for 2023.

Pharma 246

Pharma Medical Biopharma 246

Fierce Pharma

MARCH 16, 2023

Novo Nordisk hit with two-year suspension from UK pharma group after online marketing breaches fkansteiner Thu, 03/16/2023 - 09:00

Marketing 250

Marketing Pharma 250

Fierce Pharma

FEBRUARY 8, 2023

Biden takes aim at pharma in SOTU speech, vowing to defend IRA from repeal efforts kdunleavy Wed, 02/08/2023 - 10:38

Pharma 244

Pharma 244

Fierce Pharma

MAY 11, 2023

After Shkreli's run in with the law, Pharma Bro's former company Vyera files for bankruptcy fkansteiner Thu, 05/11/2023 - 11:06

Pharma 244

Pharma 244

Fierce Pharma

APRIL 18, 2023

Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A aarmstrong Tue, 04/18/2023 - 09:47

Pharma 239

Pharma 239

Fierce Pharma

MAY 16, 2023

Wyden blasts Big Pharma for tax ploys and lack of cooperation in probe kdunleavy Tue, 05/16/2023 - 10:51

Pharma 235

Pharma 235

Fierce Pharma

JUNE 12, 2024

As some pharma giants pump the brakes on big M&A deals, Bristol Myers Squibb—hot off a series of rapid-fire acquisitions in 2023—says it still has dealmaking cash to deploy if the right target | As some pharma giants pump the brakes on big M&A deals, Bristol Myers Squibb—hot off a series of rapid-fire acquisitions in 2023—says it still has (..)

Pharma 299

Pharma 299

Fierce Pharma

FEBRUARY 5, 2024

After leading Novartis and Roche through pivotal years in 2023, the CEOs of the Swiss drug giants each netted multimillion-dollar compensation packages. After leading Swiss drug giants Novartis and Roche through pivotal years, their CEOs have each netted multimillion-dollar compensation packages for 2023.

Leads 277

Leads 277

Fierce Pharma

JANUARY 11, 2023

Lilly, Biogen and more gear up for blockbuster launches in 2023: report. Wed, 01/11/2023 - 10:19.

247

247

Fierce Pharma

DECEMBER 13, 2022

Eli Lilly says 4 new launches will help drive its 2023 revenue past $30B. Tue, 12/13/2022 - 12:29.

271

271

Fierce Pharma

MAY 16, 2024

The momentum the biopharma industry showed in the fourth quarter of 2023 has continued into this year. | The momentum the biopharma industry showed in the fourth quarter of 2023 has continued into this year.

Biopharma 265

Biopharma Pharma 265

Fierce Pharma

SEPTEMBER 7, 2023

Analysts anticipate that the trend will continue in 2023 and into 2024 as companies attempt to beef up their portfolios. Biopharma M&A is on an uptick compared to the post-pandemic doldrums of the last two years. Biopharma M&A is on an uptick compared to the post-pandemic doldrums of the last two years.

Biopharma 304

Biopharma Pharma 304

MedCity News

JANUARY 3, 2023

For EVOQ, the Gilead deal is its second with a big pharma company. Gilead Sciences is building up its autoimmune disease drug pipeline by turning to EVOQ Therapeutics, a startup with technology that takes a novel approach to restoring immune tolerance.

Pharma 246

Pharma Biopharma 246

MedCity News

APRIL 13, 2023

Rejection of Eli Lilly’s mirikizumab means that two of the four drugs the pharma giant identified as revenue growth drivers for 2023 have failed to pass the regulatory bar. One of those drugs has been approved while the fourth drug still awaits an FDA decision.

FDA 298

FDA Manufacturing Pharma Biopharma 298

Fierce Pharma

FEBRUARY 1, 2024

With Merck reporting a whopping $25 billion sales haul for | With Merck reporting a whopping $25 billion sales haul for Keytruda on Thursday, the PD-1 cancer superstar appears to be the world’s top-selling drug in 2023. billion in 2022 and $55.1 billion in 2021.

Sales 278

Sales 278

Fierce Pharma

NOVEMBER 6, 2024

Drugs for unmet needs and those from experienced companies had the best chance for successful launches in 2023: report kdunleavy Wed, 11/06/2024 - 09:23

226

226

Fierce Pharma

APRIL 12, 2024

Davis, 57, received a 9% bump in pay in 2023 to $20.3 . | Merck CEO Robert Davis has cracked the $20-million mark in annual pay for the first time, putting him in an exclusive club of biopharma heavy hitters. million, according to the company’s proxy filing.

Biopharma 211

Biopharma 211

eMediWrite

APRIL 1, 2025

Ethical Use of Big Data for Precision Marketing* Pharma marketers now have access to massive datasets from electronic health records (EHRs), social media, and prescribing trends. Real-world evidence (RWE) enables pharma brands to craft more targeted marketing messages. “AI in Pharma Marketing: The Next Frontier.”

Marketing 52

Marketing Pharma Ethics Doctors 52

Fierce Pharma

FEBRUARY 20, 2024

AstraZeneca CEO Pascal Soriot’s compensation package makes him the current top contender for 2023’s highest-paid pharma CEO in Europe. Still, as in years past, not everyone is pleased with Soriot’s 2023 windfall.

Pharma 247

Pharma 247

Fierce Pharma

SEPTEMBER 19, 2023

Novo Nordisk’s shares continued to trend downward Tuesday after reports surfaced that the FDA had recently flagged manufacturing shortfalls at the Danish drugmaker’s Clayton, North Carolina product | After inspecting Novo’s Clayton, North Carolina, facility between July 6 and July 13, 2023, the FDA officially chided the company for a pair of quality (..)

FDA 275

FDA Manufacturing Pharma 275

Fierce Pharma

JANUARY 31, 2024

billion in sales in 2023 compared to $890 million for Pfizer's Abrysvo. But the British pharma major says that the successful launch represents just one round of a boxing match, and much is still to be decided, especially with Moderna expected to join the battle in 2024.

Sales 290

Sales Pharma 290

Fierce Pharma

FEBRUARY 1, 2024

As Roche CEO Thomas Schinecker sees it, the Swiss pharma made a “major achievement” in 2023. Despite a sharp decline in COVID-related sales, the company was able to grow overall revenues | As Roche CEO Thomas Schinecker sees it, the Swiss pharma made a “major achievement” in 2023.

Sales 226

Sales Pharma 226

Fierce Pharma

OCTOBER 2, 2023

After laying out a goal to launch four new drugs in 2023, Eli Lilly has run into yet another regulatory snag. | The FDA has rejected Lilly’s investigational atopic dermatitis treatment lebrikizumab over findings uncovered during the inspection of a third-party contract manufacturing organization.

FDA 218

FDA Manufacturing 218

Contrarian Sales Techniques

NOVEMBER 19, 2024

It’s a reality for many of us in pharma sales in Malaysia. In 2023, the Ministry of Health reported that over 1,600 websites selling illegal pharmaceutical products were blocked, highlighting the scale of the issue. Why This Hits Close to Home for Pharma Reps As someone in pharma sales, this problem feels personal.

Medicine 52

Medicine Sales Pharma Doctors 52

Fierce Pharma

FEBRUARY 7, 2024

With the previous year in the rearview and exciting developments already in the mix for 2024, Novo Nordisk’s CEO is taking home a cool 13% raise for his performance in 2023.

199

199

Fierce Pharma

NOVEMBER 6, 2023

Following suit with other companies that produce COVID-19 vaccines, BioNTech has discovered demand for its Pfizer-partnered, omicron-adapted shot has not met expectations this fall and has had to a | BioNTech has slashed its estimate of 2023 revenue by 20%, now expecting it to reach 4 billion euros ($4.3

Sales 207

Sales 207

Fierce Pharma

SEPTEMBER 12, 2023

Xspray Pharma, before receiving an FDA slapdown in July, had expected to launch its competitor to Bristol Myers Squibb’s leukemia blockbuster Sprycel within the second half of 2023. Xspray and BMS have settled patent litigation around their potential rivals Dasynoc and Sprycel, Xspray said Tuesday.

FDA 262

FDA Pharma 262

Fierce Pharma

JULY 27, 2023

To Roche’s pharma chief Teresa Graham, no word better describes the company’s eye drug Vabysmo right now than “momentum.” | To Roche’s pharma chief Teresa Graham, no word better describes the company’s eye drug Vabysmo right now than “momentum.”

FDA 223

FDA Pharma Sales 223